InvestorsHub Logo
Followers 67
Posts 1293
Boards Moderated 0
Alias Born 08/12/2014

Re: None

Tuesday, 01/05/2021 10:58:25 AM

Tuesday, January 05, 2021 10:58:25 AM

Post# of 701961
At this point only thing that makes sense that can explain the current situation of the delayed-than-usual Q3 and TLD, and as well as no significant (or almost none) warrant exercising, or even no talks about warrant further extension or much needed financing ...

is either an outright buyout negotiation or a major partnership discussion, hence the company is in a quiet period.

All other speculation just cannot explain, including my previous speculation of regulatory negotiation.

If a buyout or partnership speculation is true, then the company definitely cannot release Q3 and may not be in a position to release TLD bound by pre-arrangement of first negotiation right.

Of course if the first negotiation such as with Merck falls apart, then the bound would be relieved.

And if the above speculation is true, as I said before then the price will substantially appreciate as a harbinger of a closed or close to closed deal is made.

Linda should serve as next director of CIA for nobody in the US can keep a secret the way it should like her!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News